Malignant Melanoma Archive - Seite 5 von 19 - IOZK

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

2017-11-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-11-01 / Cancer Immunol. Immunother. 2018 02;67(2):285-298

Dendritic cell therapy in melanoma

2017-10-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-10-01 / Ann Transl Med 2017 Oct;5(19):386

Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience

2017-08-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-08-01 / Melanoma Res 2017 08;27(4):351-357

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

2017-06-27/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-06-27 / Oncotarget 2017 Sep;8(40):67439-67456

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients

2017-04-20/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-04-20 / JCI Insight 2017 Apr;2(8)

Dendritic cell vaccines for melanoma: past, present and future

2016-11-29/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-11-29 / Melanoma Manag 2016 Dec;3(4):273-289

Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells

2016-10-18/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-10-18 / Oncoimmunology 2016;5(11):e1232237

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

2016-07-29/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-29 / Ophthalmology 2016 10;123(10):2265-7

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

2016-07-18/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-18 / Case Rep Med 2016;2016:9639585

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

2016-06-20/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-20 / Hum Vaccin Immunother 2016 10;12(10):2523-2528